Abstract: The present invention relates to compositions for rectal use comprising honey in a weight percentage up to 95% w/w and glycerine in a weight percentage of between 2-40% w/w for the treatment of constipation in a subject in need thereof. The present invention also relates to a kit of parts comprising such a composition.

Abstract: The present invention relates to fractions of extracts of Helichrysum having mucoadhesive and barrier effect properties, compositions comprising said fractions, their uses and methods for the preparation of said fractions and said compositions.

Abstract: The present application relates to a composition consisting of honey, beeswax and cocoa butter, characterized by a melting temperature of 36±3° C., pharmaceutical, veterinary or cosmetic formulations comprising or coated by said composition, and processes for the preparation of said composition and said formulations.

Abstract: The present application relates to a composition for the treatment of persistent cough, suitable also for pediatric use, processes for the preparation of said composition, and a method for the treatment of persistent cough in adult individuals or in individuals of pediatric age by means of the administration of pharmaceutically effective doses of the above-mentioned composition.

Abstract: The present invention relates to compositions for rectal use comprising honey in a weight percentage up to 95% w/w and glycerine in a weight percentage of between 2-40% w/w for the treatment of constipation in a subject in need thereof. The present invention also relates to a kit of parts comprising such a composition.

Abstract: The present invention relates to an extract of Filipendula vulgaris and also to compositions and kits that comprise said extract, for the prevention and/or the treatment of a pathological condition characterised by a constitutive activation of the STAT3 transcription factor.

Abstract: The present invention relates to an extract of Cynara spp. and also to compositions and kits that comprise said extract for the prevention and/or the treatment of a pathological condition characterised by a constitutive activation of the STAT3 transcription factor.

Abstract: The present invention relates to a new extract of Cassia acutifolia and/or Cassia angustifolia in which only traces of total sennosides and resins are present, a process for the preparation of said extract, compositions comprising it, and the use of the extract and of the compositions for the protection of the skin or mucous membranes.

Abstract: The present invention relates to a new fraction of sage extract in which only traces of rosmarinic acid, carnosic acid and derivatives thereof and resins are present, a process for the preparation of such extract, compositions comprising it, and the use of the extract fraction and of the compositions for the protection of the skin or mucous membranes.

Abstract: The present invention relates to a new incense extract wherein only traces of boswellic acids and resins are present, a process for the preparation of such extract, compositions comprising it, and the use of the extract and of the compositions for the protection of the skin or the mucous membranes.

Abstract: The present invention relates to compositions comprising substances of natural origin for use in the treatment or preventing the onset or the aggravation of diabetic foot ulcers.

Abstract: The treatment of skin lesions and wounds represents one of the eldest problems for humankind and since ancient times remedies have been sought in order to facilitate the repairing of skin tissue with a consequent recovery of a healthy and elastic skin.

Abstract: The present invention refers to a prebiotic mixture comprising at least one plant polysaccharide fibre and at least one of Propolis and/or Olea europaea and/or Aloe vera extracts, optionally comprising also Thymus vulgaris and/or Agrimonia eupatoria extracts. Moreover, the present invention also relates to said mixture for use in the preservation and/or in the restoration of the intestinal microbiota balance.

Abstract: The present invention relates to an effective formulation for the treatment or the prevention of irritable bowel syndrome, a method for treating irritable bowel syndrome, and processes for preparing such formulations.

Abstract: Disclosed is the use of hypericum (Hypericum perforatum L.) tip extracts containing hypericin, of hypericin, to prepare medicinal products and/or food supplements for the treatment of neuropathic pain.

Abstract: The present invention relates to a water insoluble helychrisum extract, a process for preparing the same and its use for preparing pharmaceutical compositions for oral and/or topical administration. Furthermore, the present invention relates to the pharmaceutical compositions including said extract.

Abstract: The present invention relates to a water insoluble helychrisum extract, a process for preparing the same and its use for preparing pharmaceutical compositions for oral and/or topical administration. Furthermore, the present invention relates to the pharmaceutical compositions including said extract.

Abstract: Method of selecting and preparing medical devices comprising extracts of plants and natural substances devoid of pharmacologically, immunologically or metabolically active fractions and characterised by a content of substances able to exert beneficial effects on the body, mediated by mechanical or physical effects, which said process comprises: a) removal by conventional processes of any pharmacologically, immunologically or metabolically active fractions from extracts of plants or natural substances; b) biological testing to establish that the extract or substance obtained in a) is devoid of pharmacological, metabolic and immunological effects; c) formulation of the extracts or substances that pass the test conducted at stage b) into suitable medical devices.

Abstract: Disclosed is the use of hypericum (Hypericum perforatum L.) tip extracts containing hypericin, of hypericin, to prepare medicinal products and/or food supplements for the treatment of neuropathic pain.

Abstract: Disclosed is the use of hypericum (Hypericum perforatum L.) tip extracts containing hypericin, of hypericin, to prepare medicinal products and/or food supplements for the treatment of neuropathic pain.